{"id":"mizolastine","rwe":[{"pmid":"41269204","year":"2025","title":"Mizolastine-loaded spanlastics for treatment of atopic dermatitis: immunomodulatory approach for management of inflammation.","finding":"","journal":"Journal of drug targeting","studyType":"Clinical Study"},{"pmid":"39988211","year":"2025","title":"Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation.","finding":"","journal":"Toxicology letters","studyType":"Clinical Study"},{"pmid":"39801109","year":"2025","title":"In silico Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy.","finding":"","journal":"Turkish journal of pharmaceutical sciences","studyType":"Clinical Study"},{"pmid":"39658752","year":"2025","title":"Preclinical and clinical studies on Qin-Zhu-Liang-Xue decoction: insights from network pharmacology and implications for atopic dermatitis treatment.","finding":"","journal":"Frontiers of medicine","studyType":"Clinical Study"},{"pmid":"39238341","year":"2024","title":"Derivatization-free sustainable spectrofluorimetric estimation of antihistamine drug mizolastine in pharmaceutical and biological matrices.","finding":"","journal":"Luminescence : the journal of biological and chemical luminescence","studyType":"Clinical Study"}],"tags":[{"label":"mizolastine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"KCNH2","category":"gene"},{"label":"ALOX5","category":"gene"},{"label":"R06AX25","category":"atc"},{"label":"Active","category":"status"},{"label":"Allergic rhinitis","category":"indication"},{"label":"Perennial allergic rhinitis","category":"indication"},{"label":"Sanofi","category":"company"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists, Non-Sedating","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Sanofi","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=MIZOLASTINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:22:06.862894+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:22:12.409136+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MIZOLASTINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:22:12.769416+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Histamine H1 receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:13.881704+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL94454/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:13.488294+00:00"}},"allNames":"mizollen","offLabel":[],"synonyms":["SL-85.0324","SL 85.0324","mizolastine","mistamine","mizollen","zolistan"],"timeline":[{"date":"2003-03-07","type":"positive","source":"DrugCentral","milestone":"UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval (Sanofi)"}],"approvals":[{"date":"2003-03-07","orphan":false,"company":"SANOFI","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)"}],"brandName":"Mizollen","ecosystem":[{"indication":"Allergic rhinitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""}],"globalPrevalence":null},{"indication":"Perennial allergic rhinitis","otherDrugs":[{"name":"methylprednisolone acetate","slug":"methylprednisolone-acetate","company":"Pharmacia And Upjohn"}],"globalPrevalence":null}],"mechanism":{"target":"Histamine H1 receptor","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor"},{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"},{"gene":"ALOX5","source":"DrugCentral","target":"Arachidonate 5-lipoxygenase","protein":"Arachidonate 5-lipoxygenase"}],"modality":"Small Molecule","drugClass":"mizolastine","explanation":"","oneSentence":"","technicalDetail":"Mizolastine acts as a competitive antagonist at the histamine H1 receptor, inhibiting the binding of histamine and subsequent downstream signaling pathways involved in the allergic response."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1824","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=MIZOLASTINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MIZOLASTINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:08:20.562971","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:15.151322+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cyproheptadine","drugSlug":"cyproheptadine","fdaApproval":"1961-10-17","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"antazoline","drugSlug":"antazoline","fdaApproval":"1990-04-30","relationship":"same-class"},{"drugName":"triprolidine","drugSlug":"triprolidine","fdaApproval":"1983-05-17","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"azatadine","drugSlug":"azatadine","fdaApproval":"1977-03-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-class"},{"drugName":"terfenadine","drugSlug":"terfenadine","fdaApproval":"","relationship":"same-class"},{"drugName":"loratadine","drugSlug":"loratadine","fdaApproval":"1993-04-12","genericCount":29,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketotifen","drugSlug":"ketotifen","fdaApproval":"1999-07-02","patentExpiry":"Mar 27, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"acrivastine","drugSlug":"acrivastine","fdaApproval":"1994-03-25","relationship":"same-class"},{"drugName":"azelastine","drugSlug":"azelastine","fdaApproval":"1996-11-01","patentExpiry":"Jun 4, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"epinastine","drugSlug":"epinastine","fdaApproval":"2003-10-16","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fexofenadine","drugSlug":"fexofenadine","fdaApproval":"1996-07-25","patentExpiry":"Aug 2, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"desloratadine","drugSlug":"desloratadine","fdaApproval":"2001-12-21","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"mizolastine","indications":{"approved":[{"name":"Allergic rhinitis","source":"DrugCentral","snomedId":61582004,"regulator":"FDA"},{"name":"Perennial allergic rhinitis","source":"DrugCentral","snomedId":446096008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cyproheptadine","brandName":"cyproheptadine","genericName":"cyproheptadine","approvalYear":"1961","relationship":"same-class"},{"drugId":"antazoline","brandName":"antazoline","genericName":"antazoline","approvalYear":"1990","relationship":"same-class"},{"drugId":"triprolidine","brandName":"triprolidine","genericName":"triprolidine","approvalYear":"1983","relationship":"same-class"},{"drugId":"azatadine","brandName":"azatadine","genericName":"azatadine","approvalYear":"1977","relationship":"same-class"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-class"},{"drugId":"terfenadine","brandName":"terfenadine","genericName":"terfenadine","approvalYear":"","relationship":"same-class"},{"drugId":"loratadine","brandName":"loratadine","genericName":"loratadine","approvalYear":"1993","relationship":"same-class"},{"drugId":"ketotifen","brandName":"ketotifen","genericName":"ketotifen","approvalYear":"1999","relationship":"same-class"},{"drugId":"acrivastine","brandName":"acrivastine","genericName":"acrivastine","approvalYear":"1994","relationship":"same-class"},{"drugId":"azelastine","brandName":"azelastine","genericName":"azelastine","approvalYear":"1996","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT01928316","phase":"PHASE1","title":"A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Xian-Janssen Pharmaceutical Ltd.","startDate":"2009-06","conditions":["Healthy"],"enrollment":24,"completionDate":"2009-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"007534","UNII":"244O1F90NA","CHEBI":"CHEBI:31857","INN_ID":"6663","RXNORM":"153888","UMLSCUI":"C0171302","chemblId":"CHEMBL94454","ChEMBL_ID":"CHEMBL94454","KEGG_DRUG":"D01117","DRUGBANK_ID":"DB12523","PUBCHEM_CID":"65906","SNOMEDCT_US":"320830000","IUPHAR_LIGAND_ID":"10102","MESH_SUPPLEMENTAL_RECORD_UI":"C076170"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Sanofi","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","halfLife":"9.6 hours","clearance":"1.03 mL/min/kg","bioavailability":"65%","volumeOfDistribution":"0.38 L/kg"},"publicationCount":125,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R06AX25","allCodes":["R06AX25"]},"biosimilarFilings":[],"originalDeveloper":"Sanofi","recentPublications":[{"date":"2025 Dec 3","pmid":"41269204","title":"Mizolastine-loaded spanlastics for treatment of atopic dermatitis: immunomodulatory approach for management of inflammation.","journal":"Journal of drug targeting"},{"date":"2025 Apr","pmid":"39988211","title":"Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation.","journal":"Toxicology letters"},{"date":"2025 Jan 10","pmid":"39801109","title":"In silico Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy.","journal":"Turkish journal of pharmaceutical sciences"},{"date":"2025 Feb","pmid":"39658752","title":"Preclinical and clinical studies on Qin-Zhu-Liang-Xue decoction: insights from network pharmacology and implications for atopic dermatitis treatment.","journal":"Frontiers of medicine"},{"date":"2024 Sep","pmid":"39238341","title":"Derivatization-free sustainable spectrofluorimetric estimation of antihistamine drug mizolastine in pharmaceutical and biological matrices.","journal":"Luminescence : the journal of biological and chemical luminescence"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"1998","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"UK Medicines and Healthcare Products Regulatory Agency (MHRA)","status":"approved","approval_date":"2003-03-07T00:00:00.000Z","mah":"SANOFI","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:15.151322+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}